middle.news
Mayne Pharma Elevates CFO Aaron Gray to CEO in Smooth Leadership Shift
9:44am on Monday 23rd of February, 2026 AEDT
•
Healthcare
Read Story
Mayne Pharma Elevates CFO Aaron Gray to CEO in Smooth Leadership Shift
9:44am on Monday 23rd of February, 2026 AEDT
Key Points
Shawn Patrick O’Brien steps down as CEO, remains advisor until May 2026
Aaron Gray appointed CEO, previously CFO with 20+ years’ experience
Gray’s remuneration includes US$600,000 salary and US$300,000 RSU sign-on bonus
Company initiates search for new CFO to support next phase
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MAYNE PHARMA (ASX:MYX)
OPEN ARTICLE